April 20, 2021
It’s become increasingly clear that even healthy people with mild cases of COVID-19 can battle a constellation of symptoms that worsen over time—or which sometimes disappear only to come right back. These symptoms are part of what’s called “Long COVID Syndrome.”
Study Finds 1 in 10 Healthcare Workers with Mild COVID Have Lasting Symptoms
April 20, 2021
Researchers have found a causal link between caesarean section birth, low intestinal microbiota and peanut sensitivity in infants, and they report the effect is more pronounced in children of Asian descent than others, in a recently published article.
Food allergies, changes to infant gut bacteria linked to method of childbirth, ethnicity
April 20, 2021
Exposure to certain endocrine-disrupting chemicals could elevate the risk of breast cancer, according to a new comprehensive systematic review of epidemiological research. However, for many chemicals, evidence is inconsistent or still limited.
Review summarizes known links between endocrine disruptors and breast cancer risk
April 20, 2021
For the first time, a study has shown a clear link between the frequency and duration of unconscious wakefulness during night-time sleep and an increased risk of dying from diseases of the heart and blood vessels, and death from any cause, particularly in women.
Disrupted sleep is linked to increased risk of early death, particularly in women
April 19, 2021
Taking multivitamins, omega-3, probiotics or vitamin D supplements may lessen the risk of testing positive for SARS-CoV-2, the virus responsible for COVID-19 infection -- at least among women, indicates a large population study.
Multivitamins, omega-3, probiotics, vitamin D may lessen risk of positive COVID-19 test
April 17, 2021
With the Johnson & Johnson COVID-19 vaccine still on pause in the U.S. after reports of a rare but severe blood clotting disorder in a small number of the roughly 7 million people who've received the shot, health experts now are focusing on what could be behind those uncommon adverse events.
April 16, 2021
Primary prevention is the only means to reduce breast cancer incidence, yet many aspects of primary prevention need to be informed by a better understanding of the molecular mechanisms of risk leading to cancer onset, of the means and biomarkers to evaluate cancer risk in individuals (in order to tailor interventions to the risk level), and of socioeconomic impacts of primary prevention programs. In addition, the global burden of breast cancer, particularly in young women, requires that we integrate noninvasive screening methods that are scalable to better assess risk. The goal of this special issue is to gather information and solutions to help reduce breast cancer incidence from all concerned disciplines in the life science, social science, engineering and data science, medicine and humanities. Particular interest is in studies that are analyzing and identifying the impact of risk factors and protective factors on the molecular mechanisms of cellular homeostasis and on the mammary epigenome, and studies that are researching biomarkers of risk. Other topics of interest include basic and population research on synthetic and natural chemopreventive agents and on the protective effects of nutrition and exercise that constitute important pillars of an intervention program. Such investigations will be well integrated with projects in which engineering approaches are used to develop methods to measure risk and the impact of the environment on breast homeostasis. Here we define the environment as any external stimulus with an impact on the organism; therefore, this notion encompasses at minimum diet, pollution, stress and exercise. The interaction between environment and cells is likely to generate tremendous amounts of data (or big data), notably via ‘omics’ studies, which makes data science an important aspect for the success of primary prevention, especially for tailoring interventions and biomarkers to specific subpopulations and possibly individuals in the future. This special issue of Frontiers in Medicine will welcome not only data science perspectives, but also economic and ethical reflections on the process of working with individuals who present risk for a disease, but are not actually considered ill, and on the impact of data science of cancer risk on society and populations. Finally, considering that breast cancer is a global burden, articles representing diversity around the world are sought after, as well as studies that research the influence of diversity in finding solutions to reduce breast cancer incidence.
April 16, 2021
Researchers have found that autism may develop in different regions of the brain in girls than boys and that girls with autism have a larger number of genetic mutations than boys, suggesting that they require a larger 'genetic hit' to develop the disorder.
Female protective effect: Researchers find clues to sex differences in autism
April 14, 2021
The Purdue Women’s Global Health Institute (WGHI) and the Catherine Peachey Fund are announcing a new research program that will support breast cancer research projects led by Purdue faculty. The launching of the research program is built on the shared interests and goals between WGHI and the Catherine Peachey Fund to promote advances in breast cancer research and treatment and to support research that is best positioned to move from the bench to the clinic. The Catherine Peachey Fund was established in memory of Cathy Peachey, one of the founders of the Indiana Breast Cancer Coalition.
April 14, 2021
NIH study results bolster previous studies finding no growth, development differences with IVF.
